A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection.

Documenti analoghi

• Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.
  di: Robert-Guroff, M, et al.
  Pubblicazione: (1990)
• Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
  di: Lisziewicz, J, et al.
  Pubblicazione: (1993)
• Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element.
  di: Li, G, et al.
  Pubblicazione: (1993)
• Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes.
  di: Simm, M, et al.
  Pubblicazione: (1995)
• Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.
  di: Lisziewicz, J, et al.
  Pubblicazione: (1994)